Kopran Limited
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides d… Read more
Kopran Limited (KOPRAN) - Total Liabilities
Latest total liabilities as of September 2025: ₹3.12 Billion INR
Based on the latest financial reports, Kopran Limited (KOPRAN) has total liabilities worth ₹3.12 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Kopran Limited - Total Liabilities Trend (2004–2025)
This chart illustrates how Kopran Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Kopran Limited Competitors by Total Liabilities
The table below lists competitors of Kopran Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hancock & Gore Ltd
AU:HNG
|
Australia | AU$28.02 Million |
|
SVB & T Corp
OTCQX:SVBT
|
USA | $564.49 Million |
|
InspireMD Inc
NASDAQ:NSPR
|
USA | $14.36 Million |
|
IX Acquisition Corp
NASDAQ:IXAQ
|
USA | $13.70 Million |
|
Kyongbo Pharmaceutical Co Ltd
KO:214390
|
Korea | ₩171.21 Billion |
|
Tobii AB (publ)
F:24T
|
Germany | €900.00 Million |
|
Tristar Gold
OTCQB:TSGZF
|
USA | $2.60 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Kopran Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.14 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kopran Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kopran Limited (2004–2025)
The table below shows the annual total liabilities of Kopran Limited from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹3.26 Billion | +29.23% |
| 2024-03-31 | ₹2.52 Billion | +19.74% |
| 2023-03-31 | ₹2.10 Billion | +13.93% |
| 2022-03-31 | ₹1.85 Billion | -4.96% |
| 2021-03-31 | ₹1.94 Billion | +6.92% |
| 2020-03-31 | ₹1.82 Billion | -1.13% |
| 2019-03-31 | ₹1.84 Billion | +7.67% |
| 2018-03-31 | ₹1.71 Billion | +3.32% |
| 2017-03-31 | ₹1.65 Billion | +6.56% |
| 2016-03-31 | ₹1.55 Billion | -12.15% |
| 2015-03-31 | ₹1.77 Billion | -4.31% |
| 2014-03-31 | ₹1.84 Billion | +11.07% |
| 2013-03-31 | ₹1.66 Billion | +1.00% |
| 2012-03-31 | ₹1.64 Billion | +8.37% |
| 2011-03-31 | ₹1.52 Billion | -5.12% |
| 2010-03-31 | ₹1.60 Billion | -6.18% |
| 2009-03-31 | ₹1.70 Billion | -14.00% |
| 2008-03-31 | ₹1.98 Billion | -38.57% |
| 2007-03-31 | ₹3.23 Billion | -6.01% |
| 2006-03-31 | ₹3.43 Billion | -2.86% |
| 2005-03-31 | ₹3.53 Billion | +12.96% |
| 2004-03-31 | ₹3.13 Billion | -- |